OTC Stockz
No Result
View All Result
Monday, March 27, 2023
  • Login
  • Home
  • OTC Stocks
  • Micro Caps
  • Stocks
  • Cryptocurrency
  • NFTs
  • Education
  • Home
  • OTC Stocks
  • Micro Caps
  • Stocks
  • Cryptocurrency
  • NFTs
  • Education
OTC Stockz
No Result
View All Result
Home Micro Caps

Analyst Beefs Up Replimune Price Target As Recent Data Validates Treatment Platform – Replimune Group (NASDAQ:REPL)

by OTC Stockz
December 14, 2022
in Micro Caps
Reading Time: 1 min read
0 0
A A
0
Analyst Beefs Up Replimune Price Target As Recent Data Validates Treatment Platform – Replimune Group (NASDAQ:REPL)
Share on FacebookShare on Twitter

  • Last Thursday, Replimune Group Inc REPL announced an initial data snapshot from the first 75 patients from the anti-PD1 failed cutaneous melanoma cohort of the IGNYTE clinical.
  • The overall response rate (ORR) was 36%, and the complete response (CR) rate was 20% compared to the 12.5% shown in the prior 16 patients presented in June 2022.
  • BMO Capital Markets raised the price target to $70 from $40, with an Outperform rating.
  • The improved CR paired with longer-term durability beat the 28% hurdle rate needed to support a filing.
  • The analyst says that the updated price target reflects a 60% probability of success in the U.S. and 30% ex-US based on IGNYTE data.
  • The analyst writes that data demonstrate an unprecedented response to oncolytic therapy, which has been criticized historically for unremarkable efficacy, despite favorable safety.
  • BMO also writes that data not only provides the PoC investors needed but it also validates both the skin cancer franchise and the oncolytic virus platform.
    Price Action: REPL shares are up 3.16% at $25.79 on the last check Monday.

Read more…

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

No Result
View All Result
  • Trending
  • Comments
  • Latest
Over the counter stocks (OTC Stock)

The role of market makers in over the counter stocks (OTC Stocks)

March 6, 2023
5 Common Mistakes to Avoid When Investing in Over the Counter (OTC) Stocks

5 Common Mistakes to Avoid When Investing in Over the Counter (OTC) Stocks

February 27, 2023
Why Are Stocks Down Today?

The Future of OTC Stocks: Navigating the Changing Landscape of Over-the-Counter Investments

February 13, 2023
Over the counter stocks (OTC Stock)

The Benefits of Investing in Over-The-Counter (OTC) Stocks

February 10, 2023
Over the counter stocks (OTC Stock)

Breaking Down the World of Over-the-Counter Stocks (OTC Stock): A Comprehensive Guide

February 10, 2023
In the penny stock market, Xcelerate, Inc. (OTC: XCRT) is emerging as a top Healthcare Services stock to watch in 2022. 

Fabian Urquijo Joins the Advisory Board of Xcelerate, Inc. (OTCMKT: XCRT)

February 2, 2023
OTC Markets Group Welcomes M.O.B.A. Network to OTCQX

Drive Shack Inc. Joins the OTCQX Best Market

January 31, 2023
New York Considers Bill to Establish Cryptocurrency as a Form of Payment for State Agencies

New York Considers Bill to Establish Cryptocurrency as a Form of Payment for State Agencies

January 30, 2023
OTC Stockz

Get the latest news and follow the coverage of OTC Stocks, Micro Caps, Cryptocurrency, NFTs and more from the top trusted sources.

CATEGORIES

  • Cryptocurrency
  • Micro Caps
  • NFTs
  • OTC Stocks
  • Stock Market
  • Stock Market Education
  • Trending
  • Writers Analysis

LATEST UPDATES

  • The role of market makers in over the counter stocks (OTC Stocks)
  • 5 Common Mistakes to Avoid When Investing in Over the Counter (OTC) Stocks
  • Home
  • Disclaimer
  • Privacy Policy
  • DMCA
  • Cookie Privacy Policy
  • Terms and Conditions
  • Contact us

Copyright © 2022 OTC Stockz.
OTC Stockz is not responsible for the content of external sites.

No Result
View All Result
  • Home
  • OTC Stocks
  • Micro Caps
  • Stocks
  • Cryptocurrency
  • NFTs
  • Education

Copyright © 2022 OTC Stockz.
OTC Stockz is not responsible for the content of external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Verified by MonsterInsights